Cerebral Oxygenation and Metabolism After Reversal Of Rocuronium: Comparison Between Sugammadex Versus Neostigmine

• Status: Unknown status
• Trial end date: 2019-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Cholinesterase inhibitors such as Neostigmine and Edrophonium have been used to reverse neuromuscular blockade after surgery. However, these drugs have a relatively slow onset and have adverse effects associated with stimulation of muscarinic receptors. In addition, neostigmine cannot be used to reverse profound blockade.

Anesthetics may exert their effects on various facets of cerebral function such as cerebral metabolic rate (CMRO2), cerebral blood flow (CBF), cerebral blood flow-metabolism coupling, intra cranial pressure (ICP), autoregulation, vascular response to CO2 and brain electrical activity. The net result of all these effects of the anaesthetic agents combined with their systemic effects may prove beneficial or detrimental to an already diseased brain.

In neurosurgical patients, clear and rapid recovery is required to early assess the neurological status and to maintain the cerebral oxygenation and metabolism within the normal physiological values which may be saved by sugammadex.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mansoura University
• Treatments: Neostigmine; Neuromuscular Blocking Agents; Rocuronium

Criteria

Inclusion Criteria:

• American Society of Anesthesiologists physical class status I - III .

• Patients scheduled for elective supratentorial brain tumor resection

Exclusion Criteria:

• Severe uncompensated cardiac disease.

• Severe uncompensated respiratory disease.

• Severe uncompensated hepatic disease.

• Severe uncompensated renal disease.

• Morbidly obese patients.

• Documented hypersensitivity to one of the used drugs.

• Surgery in sitting position

• Surgery in prone position

• Patients with altered level of consciousness.

• Pregnancy.